Germany · Delayed Price · Currency is EUR BioNxt Solutions Statistics
Total Valuation
FRA:BXT has a market cap or net worth of EUR 69.62 million. The enterprise value is 73.98 million.
| Market Cap | 69.62M |
| Enterprise Value | 73.98M |
Important Dates
The last earnings date was Wednesday, August 27, 2025.
| Earnings Date | Aug 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 120.06M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +7.92% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 112.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5,147.24 |
| PB Ratio | -13.26 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -19.62 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06
| Current Ratio | 0.06 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -392.79% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 133.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -56,059 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +318.57% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +318.57% |
| 50-Day Moving Average | 0.49 |
| 200-Day Moving Average | 0.35 |
| Relative Strength Index (RSI) | 50.95 |
| Average Volume (20 Days) | 65,308 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:BXT had revenue of EUR 13,526 and -3.77 million in losses. Loss per share was -0.03.
| Revenue | 13,526 |
| Gross Profit | 13,526 |
| Operating Income | -3.32M |
| Pretax Income | -3.83M |
| Net Income | -3.77M |
| EBITDA | -3.29M |
| EBIT | -3.32M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 2,645 in cash and 4.41 million in debt, giving a net cash position of -4.41 million.
| Cash & Cash Equivalents | 2,645 |
| Total Debt | 4.41M |
| Net Cash | -4.41M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -5.25M |
| Book Value Per Share | -0.04 |
| Working Capital | -2.69M |
Cash Flow
| Operating Cash Flow | -2.12M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -24,515.77% |
| Pretax Margin | -28,284.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:BXT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.92% |
| Shareholder Yield | n/a |
| Earnings Yield | -5.41% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:BXT has an Altman Z-Score of -188.93 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -188.93 |
| Piotroski F-Score | 2 |